1 not yet recruiting, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Rheumatoid Arthritis (RA: new trials by email Literature Review of Rheumatoid Arthritis (RA trials Research Report on Rheumatoid Arthritis (RA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Iguratimod in Combination With Tofacitinib in RA Patients Combined therapy of Iguratimod and tofacitinib - Rheumatoid Arthritis (RA | Phase 4 | Not yet recruiting | Jie Chang | 200 | 2025-08-01 | 2025-04-25 |
| JAK Inhibitor Dose TAPering Strategy Study Baricitinib (LY3009104) 4 mg, filgotinib 200mg/day, Tofacitinib 5 mg twice daily - Rheumatoid Arthritis (RA | Phase 4 | Recruiting | University Hospital, Toulouse | 308 | 2025-06-06 | 2026-08-07 |
Arthritis (2) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Rheumatic Diseases (2) · Skin and Connective Tissue Diseases (2)
tofacitinib (2) · GLPG0634 (1) · Psychotherapy, Multiple (1) · baricitinib (1) · iguratimod (1) · upadacitinib (1)
Jie Chang (1) · University Hospital, Toulouse (1)
China (1) · France (1)
2023 (1)